AIMST University is proud to be part of the Noble Venture

The National Vaccine Development Roadmap (PPVN) and Malaysian Genome and Vaccine Institute (MGVI) was launched by YAB Dato’ Sri Ismail Sabri Yaakob, Prime Minister of Malaysia on 1 November 2021 at the Malaysian Genome Institute (MGI) in Bangi.

USM-AIMST University & MOSTI will jointly work on the “Development of Mucosal/Oral/Subunit Vaccines against Traveller’s Diarrhoea/Cholera, Tuberculosis and COVID-19.”

These projects will be funded by MOSTI – Strategic Research Fund (SFR), amounting to RM10.5 million. AIMST University is proud to be part of the noble venture in developing the vaccine for cholera that will undergo first-in-human trial and vaccine for Covid-19 & its variant and tuberculosis. We congratulate all the researchers involved in the project.

Click HERE  to read more on this development.